Literature DB >> 10456876

Characterization of the interaction between Yersinia enterocolitica biotype 1A and phagocytes and epithelial cells in vitro.

T Grant1, V Bennett-Wood, R M Robins-Browne.   

Abstract

Yersinia enterocolitica strains of biotype 1A are increasingly being recognized as etiological agents of gastroenteritis. However, the mechanisms by which these bacteria cause disease differ from those of highly invasive, virulence plasmid-bearing Y. enterocolitica strains and are poorly understood. We have investigated several biotype 1A strains of diverse origin for their ability to resist killing by professional phagocytes. All strains were rapidly killed by polymorphonuclear leukocytes but persisted within macrophages (activated with gamma interferon) to a significantly greater extent (survival = 40.5% +/- 17.4%) than did Escherichia coli HB101 (9.3% +/- 0.7%; P = 0.0001). Strains isolated from symptomatic patients were significantly more resistant to killing by macrophages (survival = 48.9% +/- 19.5%) than were strains obtained from food or the environment (survival = 32.1% +/- 10.3%; P = 0.04). Some strains which had been ingested by macrophages or HEp-2 epithelial cells showed a tendency to reemerge into the tissue culture medium over a period lasting several hours. This phenomenon, which we termed "escape," was observed in 14 of 15 strains of clinical origin but in only 3 of 12 nonclinical isolates (P = 0.001). The capacity of bacteria to escape from cells was not directly related to their invasive ability. To determine if escape was due to host cell lysis, we used a variety of techniques, including lactate dehydrogenase release, trypan blue exclusion, and examination of infected cells by light and electron microscopy, to measure cell viability and lysis. These studies established that biotype 1A Y. enterocolitica strains were able to escape from macrophages or epithelial cells without causing detectable cytolysis, suggesting that escape was achieved by a process resembling exocytosis. The observations that biotype 1A Y. enterocolitica strains of clinical origin are significantly more resistant to killing by macrophages and significantly more likely to escape from host cells than are strains of nonclinical origin suggest that these properties may account for the virulence of these bacteria.

Entities:  

Mesh:

Year:  1999        PMID: 10456876      PMCID: PMC96754     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells.

Authors:  V L Miller; S Falkow
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

2.  A human colonic tumor cell line that maintains vectorial electrolyte transport.

Authors:  K Dharmsathaphorn; J A McRoberts; K G Mandel; L D Tisdale; H Masui
Journal:  Am J Physiol       Date:  1984-02

3.  Plasmid-mediated early killing of eucaryotic cells by Shigella flexneri as studied by infection of J774 macrophages.

Authors:  P L Clerc; A Ryter; J Mounier; P J Sansonetti
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

4.  The pathogenesis of Yersinia enterocolitica infection in gnotobiotic piglets.

Authors:  R M Robins-Browne; S Tzipori; G Gonis; J Hayes; M Withers; J K Prpic
Journal:  J Med Microbiol       Date:  1985-06       Impact factor: 2.472

5.  Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis.

Authors:  B A McCormick; S I Miller; D Carnes; J L Madara
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

6.  Clinical significance of virulence-related assay of Yersinia species.

Authors:  M A Noble; R L Barteluk; H J Freeman; R Subramaniam; J B Hudson
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

7.  Yersinia enterocolitica biotype 1 in South Africa.

Authors:  R M Robins-Browne; M R Jacobs; H J Koornhof; A C Mauff
Journal:  S Afr Med J       Date:  1979-06-23

8.  CSF-1 stimulates Na+K+-ATPase mediated 86Rb+ uptake in mouse bone marrow-derived macrophages.

Authors:  G Vairo; J A Hamilton
Journal:  Biochem Biophys Res Commun       Date:  1985-10-15       Impact factor: 3.575

9.  The ail locus is found uniquely in Yersinia enterocolitica serotypes commonly associated with disease.

Authors:  V L Miller; J J Farmer; W E Hill; S Falkow
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

10.  The interaction of Chlamydia trachomatis with host cells: ultrastructural studies of the mechanism of release of a biovar II strain from HeLa 229 cells.

Authors:  W J Todd; H D Caldwell
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

View more
  13 in total

1.  Current evidence for human yersiniosis in Ireland.

Authors:  T Ringwood; B P Murphy; N Drummond; J F Buckley; A P Coveney; H P Redmond; J P Power; S Fanning; M B Prentice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-03       Impact factor: 3.267

2.  Homologues of insecticidal toxin complex genes in Yersinia enterocolitica biotype 1A and their contribution to virulence.

Authors:  Sharon M Tennant; Narelle A Skinner; Angela Joe; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death.

Authors:  A L Glasser; J Boudeau; N Barnich; M H Perruchot; J F Colombel; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Yersinia enterocolitica and Y. enterocolitica-like species in clinical stool specimens of humans: identification and prevalence of bio/serotypes in Finland.

Authors:  L M Sihvonen; K Haukka; M Kuusi; M J Virtanen; A Siitonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-14       Impact factor: 3.267

5.  Genetic relationships between clinical and non-clinical strains of Yersinia enterocolitica biovar 1A as revealed by multilocus enzyme electrophoresis and multilocus restriction typing.

Authors:  Sarita Mallik; Jugsharan S Virdi
Journal:  BMC Microbiol       Date:  2010-05-28       Impact factor: 3.605

6.  Symptoms and sources of Yersinia enterocolitica-infection: a case-control study.

Authors:  Elisa Huovinen; Leila M Sihvonen; Mikko J Virtanen; Kaisa Haukka; Anja Siitonen; Markku Kuusi
Journal:  BMC Infect Dis       Date:  2010-05-20       Impact factor: 3.090

7.  Molecular and biochemical characterization of urease and survival of Yersinia enterocolitica biovar 1A in acidic pH in vitro.

Authors:  Neeru Bhagat; Jugsharan S Virdi
Journal:  BMC Microbiol       Date:  2009-12-17       Impact factor: 3.605

8.  Clinical isolates of Yersinia enterocolitica biotype 1A represent two phylogenetic lineages with differing pathogenicity-related properties.

Authors:  Leila M Sihvonen; Kaisa Jalkanen; Elisa Huovinen; Susanna Toivonen; Jukka Corander; Markku Kuusi; Mikael Skurnik; Anja Siitonen; Kaisa Haukka
Journal:  BMC Microbiol       Date:  2012-09-17       Impact factor: 3.605

9.  Detection, distribution and characterization of novel superoxide dismutases from Yersinia enterocolitica Biovar 1A.

Authors:  Mahesh Shanker Dhar; Vatika Gupta; Jugsharan Singh Virdi
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  Gene polymorphism analysis of Yersinia enterocolitica outer membrane protein A and putative outer membrane protein A family protein.

Authors:  Kewei Li; Wenpeng Gu; Junrong Liang; Yuchun Xiao; Haiyan Qiu; Haoshu Yang; Xin Wang; Huaiqi Jing
Journal:  BMC Genomics       Date:  2014-03-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.